Characteristics and Analysis of Gut Microbiota in Sepsis-associated Acute Kidney Injury
Abstract
This work aimed to investigate the structural differences in gut microbiota between patients with sepsis-associated acute kidney injury (SA-AKI) and healthy individuals, and to analyze the correlations between differential microbiota and various clinical indicators. A retrospective case-control study was conducted. A total of 45 patients with SA-AKI were enrolled as the case group and 30 healthy individuals undergoing routine physical examinations as the control group. Fecal samples were collected for gut microbiota sequencing. Alpha diversity, beta diversity, and species composition characteristics of the gut microbiota were compared between the two groups. Correlation analysis was performed to identify associations between differential microbiota and clinical indicators. Compared with the control group, the case group showed significantly lower Shannon and Chao1 indices (both P < 0.01). The overall community structure of the gut microbiota differed significantly between the two groups (PERMANOVA, R2 = 0.35, P = 0.001). At the phylum level, the relative abundance of Proteobacteria was higher in the case group (35.2% vs. 4.1%), while that of Firmicutes was lower (40.1% vs. 65.8%). The abundance of opportunistic pathogens, such as Enterococcus, increased and was positively correlated with SOFA score and serum creatinine. The abundance of beneficial bacteria such as Faecalibacterium prausnitzii decreased and was negatively correlated with interleukin-6 levels. This study has limitations, including a limited sample size, a retrospective design, and a lack of metabolomic or functional validation; it represents an observational association analysis. Patients with SA-AKI exhibit marked gut microbiota dysbiosis, and this dysbiosis is correlated with disease severity and systemic inflammatory response. However, the current evidence is insufficient to confirm that the identified microbiota can directly serve as clinical biomarkers or therapeutic targets, and their clinical applicability warrants further in-depth investigation.
© 2026 Huaqing Liu, Wei Zhang, Yinghui Tian, Dawei Wang, Fei Liu, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.